- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03763890
Post- End- Expiratory Pressure Affect the Alveolar Heterogeneity in Moderate and Sever ARDS Patients
July 17, 2022 updated by: Ling Liu, Southeast University, China
This study try to use EIT ( Electronic impedance tomography ) to evaluate the alveolar heterogeneity and use trans-pulmonary pressure and stain to evaluate the lung injury .
The study use these methods to figure out how PEEP impact the alveolar heterogeneity and VILI.
Study Overview
Detailed Description
ARDS(Acute respiratory distress syndrome )is common in patients suffering Sepsis, trauma, burning and other sever condition and characterized by diffuse alveolar damage and alveolar heterogeneity.ARDS patient need MV(mechanical ventilation )to maintain oxygenation and need unique MV tragedy to avoid VILI(Ventilator induced Lung injury ).PEEP(post-end-expiratory pressure) is crucial to maintain oxygenation and avoid VILI according to researches.
But there are also some other research different voice.
This study try to use EIT ( Electronic impedance tomography ) to evaluate the alveolar heterogeneity and use trans-pulmonary pressure and stain to evaluate the lung injury .
The study use these methods to figure out how PEEP impact the alveolar heterogeneity and VILI.
Study Type
Observational
Enrollment (Anticipated)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: ling liu, PhD
- Phone Number: 13851435472
- Email: liulingdoctor@126.com
Study Contact Backup
- Name: haibo qiu, PhD
- Phone Number: professor 13951965301
- Email: haiboq@163.com
Study Locations
-
-
Jiangsu
-
Nanjing, Jiangsu, China, 210009
- Recruiting
- Nanjing Zhong-Da Hospital
-
Contact:
- Ling Liu, MD.
- Phone Number: 86-25-83272201
- Email: liulingdoctor@126.com
-
Contact:
- Haibo Qiu, PhD.,MD.
- Phone Number: 86-25-83272200
- Email: haiboq2000@yahoo.com.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Moderate or sever ARDS in 2012 <Berlin definition>;
Description
Inclusion Criteria:
- Age≥18 or<80;
- Moderate or sever ARDS in 2012 <Berlin definition>;
- Applied mechanical ventilation;
- Consent signed.
Exclusion Criteria:
- Asthma or COPD;
- Cardiogenic edema;
- Sever neutropenia(<500/mm3);
- Hemodynamic astatic: DOPA or Dobutamine >15 µg/kg/ min; NE > 15ug /min;
- GCS coma score ≤12;
- Thoracic injury or surgery patients contradict EIT ;
- Refuse to join in trail;
- Included in other clinical trail。
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
alveolar hyper-distention; alveolar collapse;alveolar opening and closing;
Time Frame: September,1,2018-December 30, 2020
|
The study use Pulmo Vista 500 device (Drager co.),is intended to perform thoracic bioimpedance measurements by applying the technique of electrical impedance tomography (EIT)to evaluate alveolar hyper-distention(%of the lung volume); alveolar collapse(% of the lung volume);alveolar opening and closing(% of the lung volume).
|
September,1,2018-December 30, 2020
|
Trans-pulmonary pressure
Time Frame: September,1,2018-December 30, 2020
|
The researchers place tube in the esophagus and connect it to transmitter to measure esophageal pressure (mmHg)and calculate trans-pulmonary pressure(mmHg) to evaluate stress
|
September,1,2018-December 30, 2020
|
EELV
Time Frame: September,1,2018-December 30, 2020
|
The research use nitrogen wash out to measure EELV(end-expiratory lung volume, ml) to calculate dynamic strain and evaluate the strain
|
September,1,2018-December 30, 2020
|
peak pressure
Time Frame: September,1,2018-December 30, 2020
|
The researchers use ventilator to measure peak pressure(cmH2O) in patients with mechanical ventilation and without spontaneous breathing..
|
September,1,2018-December 30, 2020
|
plateau pressure
Time Frame: September,1,2018-December 30, 2020
|
The researchers use ventilator to do inspiration pause to measure plateau pressure(cmH2O) in patients with mechanical ventilation and without spontaneous breathing.
|
September,1,2018-December 30, 2020
|
tidal volume
Time Frame: September,1,2018-December 30, 2020
|
The researchers use ventilator to measure tidal volume(ml) in patients with mechanical ventilation and without spontaneous breathing..
|
September,1,2018-December 30, 2020
|
respiratory rate
Time Frame: September,1,2018-December 30, 2020
|
The researchers record the set respiratory rate(bpm) in patients with mechanical ventilation.
|
September,1,2018-December 30, 2020
|
flow
Time Frame: September,1,2018-December 30, 2020
|
The researchers record the set Flow (L/min) in patients with mechanical ventilation.
|
September,1,2018-December 30, 2020
|
FiO2
Time Frame: September,1,2018-December 30, 2020
|
The researchers record the set FiO2 ( fraction of inspiratory oxygen, %) in patients with mechanical ventilation.
|
September,1,2018-December 30, 2020
|
PaO2
Time Frame: September,1,2018-December 30, 2020
|
The researchers use blood gas analysis to measure PaO2( arterial oxygen pressure,mmHg)
|
September,1,2018-December 30, 2020
|
PaCO2
Time Frame: September,1,2018-December 30, 2020
|
The researchers use blood gas analysis to measure PaCO2( arterial carbon dioxide pressure,mmHg) .
|
September,1,2018-December 30, 2020
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SBP
Time Frame: September,1,2018-December 30, 2020
|
Recording SBP(systolic pressure, mmHg),which is always continuously monitored with invasive pressure monitor.
|
September,1,2018-December 30, 2020
|
DBP
Time Frame: September,1,2018-December 30, 2020
|
Recording DBP(Diastolic pressure, mmHg),which is always continuously monitored with invasive pressure monitor.
|
September,1,2018-December 30, 2020
|
CVP
Time Frame: September,1,2018-December 30, 2020
|
Recording CVP(central venous Pressure),which is always discontinuously monitored with jugular pressure monitor mmHg).
|
September,1,2018-December 30, 2020
|
vasopressor
Time Frame: September,1,2018-December 30, 2020
|
Recording clinical vasopressor usage including Norepinephrine( μg/Kg/min;)Epinephrine(μg/Kg/min) Dobutamine ( μg/Kg/min)
|
September,1,2018-December 30, 2020
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: haibo qiu, PhD, Nanjing Zhong-Da Hospital, Southeast University School of Medicine,China
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2018
Primary Completion (Anticipated)
December 30, 2023
Study Completion (Anticipated)
December 30, 2023
Study Registration Dates
First Submitted
November 29, 2018
First Submitted That Met QC Criteria
December 3, 2018
First Posted (Actual)
December 4, 2018
Study Record Updates
Last Update Posted (Actual)
July 19, 2022
Last Update Submitted That Met QC Criteria
July 17, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 20181129PEEP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ards
-
National University Health System, SingaporeActive, not recruiting
-
King Abdul Aziz Specialist HospitalCompleted
-
Southeast University, ChinaCompleted
-
Magni FedericoUnknown
-
Wolfson Medical CenterUnknown
-
Southeast University, ChinaFirst Affiliated Hospital of Wannan Medical CollegeRecruiting
-
University Hospital, AngersCompleted
Clinical Trials on Post-end-Expiratory pressure
-
Gachon University Gil Medical CenterCompletedCerebral IschemiaKorea, Republic of
-
University of Mississippi Medical CenterRecruitingObesity | Respiratory FailureUnited States
-
Tanta UniversityRecruitingLaparoscopic Bariatric Surgery | Postoperative Atelectasis | Positive End-expiratory Pressure | Hemodynamic VariableEgypt
-
Menoufia UniversityNot yet recruitingAtelectasis, Postoperative
-
Marmara UniversityTerminatedIntraocular Pressure | Intracranial Pressure | Positive End-expiratory PressureTurkey
-
Capital Medical UniversityCompletedMechanical VentilationChina
-
Bozyaka Training and Research HospitalRecruitingRegional Cerebral Oxygen SaturationTurkey
-
Sanatorio Anchorena San MartinRecruitingAcute Respiratory Distress SyndromeArgentina
-
Università degli Studi di FerraraUniversity of MilanRecruitingVentilator-Induced Lung Injury | Mechanical Ventilation Complication | Weaning Failure | Acute Respiratory FailureItaly
-
Hospices Civils de LyonCompleted